Shaver Fund Awards 2018

February 1, 2018

The following Masonic Cancer Center members were recently awarded Shaver Fund Awards from the Randy Shaver Cancer Research and Community Fund.

Venkatram Mereddy, PhD - New Drugs for the Treatment of Glioblastoma and Breast Cancer Metastasis to Brain
Henry Balfour, MD - A Vaccine Against the First Human Cancer Virus: Epstein-Barr Virus (EBV)
Martin Felices, PhD and Melissa Geller MD, MS - Maximizing Natural Killer Cell Immunotherapy in Ovarian Cancer
Deepali Sachdev, PhD - IGF1R Targeted TriKEs and IGF1R/HER3 Targeted TetraKEs as Novel Immunotherapy for Solid Cancers
Martina Bazzaro, PhD - Testing, and Gene Expression Profiling to Detect Chemoresistant Endometrial Cancer
Emil Lou MD, PhD, FACP - Uncovering the Effects of Cancer Cell Communication Via Tunneling Nanotubes
Walter Low, PhD - Zika Virus-based Therapy for Treating Malignant Brain Tumors – Mechanisms of Action
Jayanth Panyam, PhD and Badrinath Konety, MD, PhD - Antibody-Drug Conjugate Targeting HSPG2 for Muscle-Invasive Bladder Cancer
David Potter, MD - Potentiation of Immune Checkpoint Blockade by Inhibition of Epoxyeicosatrienoic Acid Driven Tumor Respiration
Paolo Provenzano, PhD - Combination Stroma Targeting and Immune Modulating Therapies in Pancreatic Cancer
Tim Starr, PhD - Improving Natural Killer Cells for Treating Patients with Ovarian Cancer
Daniel Vallera, PhD - Enhancing Our Ability to Develop New Drugs at the University of Minnesota
Betsy Kren, PhD - Targeting Mitochondrial Trx2 for HCC Therapy
Branden Moriarity, PhD - Combined CSF1R-SEMA4D Blockade for the Treatment of Pediatric Osteosarcoma
Arpit Rao, MD - Abemaciclib as a Novel Drug Therapy in Advanced Prostate Cancer
Julia Davydova, MD, PhD and Evidio Domingo-Musibay, MD, PhD - Novel Immunotherapies for Melanoma Patients
Clark Chen, MD and Valya Ramakrishnan, PhD - A New Horizon in Glioblastoma Therapy: Targeting Tumor Interactions with Microglia

Shaver Fund